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D44 is an adhesion molecule that interacts with
hyaluronic acid (HA) and undergoes sequential
proteolytic cleavages in its ectodomain and intra-
membranous domain. The ectodomain cleavage is triggered
by extracellular Ca
 
2
 
 
 
 inﬂux or the activation of protein
kinase C. Here we show that CD44-mediated cell–matrix
adhesion is terminated by two independent ADAM family
metalloproteinases, ADAM10 and ADAM17, differentially
regulated in response to those stimuli. Ca
 
2
 
 
 
 inﬂux activates
ADAM10 by regulating the association between calmodulin
and ADAM10, leading to CD44 ectodomain cleavage.
C
 
Depletion of ADAM10 strongly inhibits the Ca
 
2
 
 
 
 inﬂux-
induced cell detachment from matrix. On the other hand,
phorbol ester stimulation activates ADAM17 through the
activation of PKC and small GTPase Rac, inducing proteolysis
of CD44. Furthermore, depletion of ADAM10 or ADAM17
markedly suppressed CD44-dependent cancer cell migration
on HA, but not on ﬁbronectin. The spatio-temporal regu-
lation of two independent signaling pathways for CD44
cleavage plays a crucial role in cell–matrix interaction and
cell migration.
 
Introduction
 
CD44 is a type I transmembrane protein and functions as
the major cellular adhesion molecule for hyaluronic acid
(HA), a component of the ECM. It is expressed in most
human cell types and is implicated in a wide variety of phys-
iological and pathological processes, including lymphocyte
homing and activation, wound healing, cell migration, as
well as tumor cell growth and metastasis (Aruffo et al., 1990;
Gunthert et al., 1991; Lesley and Hyman, 1998; Cichy and
Pure, 2003).
We reported previously that CD44 undergoes sequential
proteolytic cleavages in its ectodomain and intramembranous
domain (Fig. S1, A and B, available at http://www.jcb.org/
cgi/content/full/jcb.200310024/DC1), which play a critical
role in cancer cell migration and metastasis and various
physiological events (Okamoto et al., 2001). Cleavage of the
ectodomain is mediated by membrane-associated matrix
metalloproteinases (MMPs) and is regulated by multiple signal
pathways, such as extracellular Ca
 
2
 
 
 
 influx, the activation of
PKC, the Ras oncoprotein, and Rho family small GTPases
(Okamoto et al., 1999a; Kawano et al., 2000). Importantly,
we found that the ectodomain cleavage of CD44 induced
by PKC activation and extracellular Ca
 
2
 
 
 
 influx are regu-
lated by independent mechanisms (Okamoto et al., 1999a;
Fig. S1 C).
The release of the soluble ectodomain (soluble CD44)
from the membrane-bound COOH-terminal fragment
(CD44EXT) is responsible for dynamic regulation of the
 
The online version of this article contains supplemental material.
Address correspondence to Hideyuki Saya, Dept. of Tumor Genetics and
Biology, Graduate School of Medical Sciences, Kumamoto University,
1-1-1 Honjo, Kumamoto 860-8556, Japan. Tel.: 81-96-373-5116.
Fax: 81-96-373-5120. email: hsaya@gpo.kumamoto-u.ac.jp
Key words: CD44; ADAM10; ADAM17; calmodulin; Rac
 
Abbreviations used in this paper: HA, hyaluronic acid; HB-EGF, heparin-
binding epidermal growth factor–like growth factor; MEF, mouse
embryonic fibroblast; MMP, matrix metalloproteinase; TFP, trifluoperazine. 
894 The Journal of Cell Biology 
 
|
 
 
 
Volume 165, Number 6, 2004
 
interaction between CD44 and the ECM during cell migra-
tion on a HA-containing substratum. The ectodomain
cleavage also triggers the intramembrane cleavage of
CD44EXT by presenilin-dependent 
 
 
 
-secretase (Murakami
et al., 2003) that releases the CD44 intracellular domain
(CD44ICD) into the cytoplasm. Furthermore, we found
that CD44ICD translocates to the nucleus and activates
gene transcription that is mediated through the TPA-respon-
sive element (Okamoto et al., 2002). The ectodomain cleav-
age event thus initiates the CD44-mediated intracellular sig-
naling pathway.
It has been reported previously that membrane-type 1
MMP forms a complex with CD44 and cleaves the ecto-
domain at the leading edge of migrating cells (Kajita et al.,
2001). However, Ca
 
2
 
 
 
 influx inhibits both the conversion of
pro–membrane-type 1 MMP to the active form of the pro-
tease as well as MMP-2 activation (Yu et al., 1997). There-
fore, cleavage of the ectodomain of CD44 triggered by Ca
 
2
 
 
 
influx is likely mediated by other proteases.
CD44 ectodomain cleavage reducing/terminating HA
substrate adhesion is markedly enhanced by mechanical
stimulation of cells that induces the influx of extracellular
Ca
 
2
 
 
 
 (Okamoto et al., 1999a). Calcium regulates many of
the molecular processes that are required for cell movement
(Strohmeier and Bereiter-Hahn, 1984), e.g., in wound heal-
ing. Extracellular Ca
 
2
 
 
 
 influx was recently shown to pro-
mote the shedding not only of CD44 but also of several
other membrane proteins including heparin-binding epider-
mal growth factor–like growth factor (HB-EGF; Dethlefsen
et al., 1998) and E-cadherin (Ito et al., 1999). The influx of
extracellular Ca
 
2
 
 
 
 thus triggers cell proliferation and the dis-
assembly of cell–cell and cell–substratum adhesion com-
plexes during cell motility. However, the precise molecular
mechanism by which Ca
 
2
 
 
 
 influx induces membrane pro-
tein cleavage has remained unknown.
Here, we demonstrate that the Ca
 
2
 
 
 
 influx-induced ec-
todomain cleavage is mediated by ADAM10 metalloprotein-
ase and that ADAM10 activity is regulated by the association
with CaM. Contrarily, CD44 ectodomain cleavage induced
by phorbol ester stimulation is mediated by ADAM17
through the activation of PKC and small GTPase Rac. Thus,
our data indicate that CD44-mediated cell–matrix adhesion
is terminated by two independent ADAM family metallopro-
teinases, ADAM10 and ADAM17, which are differentially
regulated in response to Ca
 
2
 
 
 
 influx and PKC activation.
 
Results
 
ADAM10 activity is involved in CD44 
ectodomain cleavage
 
To characterize the enzymes responsible for cleavage of the
CD44 ectodomain, we first tested the effects of various in-
hibitors of metalloproteinases in a cell-free assay of CD44
cleavage which we developed previously (Ito et al., 1999;
Okamoto et al., 1999b). Crude membranes isolated from
U251MG human glioma cells, which possess substantial
CD44-cleaving activity, were incubated for 120 min at 37
 
 
 
C
and subjected to immunoblot analysis with antibodies
specific for the COOH-terminal region of CD44 (anti-
CD44cyto pAb). Such incubation increased the abundance
of a membrane-bound COOH-terminal fragment (CD44EXT;
Fig. S2 A, lane 2,
 
 
 
available at http://www.jcb.org/cgi/
content/full/jcb.200310024/DC1), and the ectodomain
cleavage was blocked by the MMP inhibitor BB94 (10 
 
 
 
M;
Fig. S2 A, lane 3) and the Ca
 
2
 
 
 
 chelator EGTA (10 mM;
Fig. S2 B, lane 4), indicating that the reaction is mediated
by an MMP and is sensitive to Ca
 
2
 
 
 
 concentration in this
cell-free system. The cleavage reaction was inhibited by tis-
sue inhibitor of metalloproteinase (TIMP)-1 and by TIMP-3,
but it was not affected by TIMP-2 (Fig. S2 A, lanes 4–6).
Given that the catalytic activities of all known MMPs, with
the exception of ADAM (a disintegrin and metalloprotease
domain) family proteins, are inhibited by TIMP-2 (Nath et
al., 2001), our results implicated either an unknown MMP
or an ADAM proteinase in the Ca
 
2
 
 
 
-dependent cleavage of
the CD44 ectodomain.
The activity of ADAM10 is inhibited by TIMP-1 or
TIMP-3 (Amour et al., 2000) and ADAM17 (also known as
TNF-
 
 
 
–converting enzyme, or TACE) is inhibited by TIMP-3
(Amour et al., 1998; Doedens et al., 2003). Activities of
these two ADAMs are not inhibited by TIMP-2. Therefore,
to test whether the activity of ADAM10 or ADAM17 medi-
ates CD44 ectodomain cleavage, we attempted to knockdown
ADAM10 or ADAM17 by application of RNA interference
Figure 1. Distinct regulation of ADAM10 
and ADAM17 in the CD44 cleavage 
induced by different stimulations. 
(A) U251MG cells were transfected with 
control, ADAM10, or ADAM17 siRNAs, 
as indicated, and cultured for 4 d. Equal 
amounts of cell lysates were then sub-
jected to immunoblot analysis with 
antibodies to ADAM10, ADAM17, or 
 -tubulin. (B) U251MG cells transfected 
with control, ADAM10, or ADAM17 
siRNAs were either subjected to me-
chanical scraping (left) or treated with 
5  M ionomycin (right) and subsequent 
incubation for 30 min. Cell lysates were 
then subjected to immunoblot analysis 
with antibodies specific for the COOH-terminal region of CD44 (anti-CD44cyto pAb) or with antibodies to ADAM10, to ADAM17, or to  -tubulin 
(loading control), as indicated. (C) U251MG cells transfected with control, ADAM10, or ADAM17 siRNAs were treated with 100 ng/ml TPA 
for 60 min (right). Cell lysates were then subjected to immunoblot analysis as in A. 
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in U251MG cells. Immunoblot analysis showed that expres-
sion of ADAM17 was not affected by ADAM10 depletion,
and vice versa (Fig. 1 A). The CD44 ectodomain cleavage af-
ter the incubation at 37
 
 
 
C was markedly inhibited in the
membrane fraction prepared from the ADAM10-depleted
cells (Fig. S2 B, lane 6) but not in that derived from cells de-
pleted of ADAM17 (Fig. S2 B, lane 8), suggesting that
ADAM10 activity mainly mediates this reaction.
 
ADAM10 and ADAM17 regulate CD44 ectodomain 
cleavage in response to distinct stimulations
 
We next examined the roles of ADAM10 and ADAM17 in
CD44 ectodomain cleavage in living cells. Depletion of
ADAM10, but not that of ADAM17, markedly inhibited
the ectodomain cleavage induced by mechanical scraping
which leads to extracellular Ca
 
2
 
 
 
 influx (Fig. 1 B, left). The
ectodomain cleavage induced by exposure to the Ca
 
2
 
 
 
 iono-
phore ionomycin was also inhibited by ADAM10 depletion
(Fig. 1 B, right). These results suggested that ADAM10 is
responsible for the Ca
 
2
 
 
 
 influx-induced CD44 ectodomain
cleavage.
As demonstrated in Fig. S1 C, CD44 ectodomain cleavage
is triggered not only by Ca
 
2
 
 
 
 influx but also by the activation
of PKC, and that these two stimuli achieve their effects by
distinct signaling pathways. Thus, we examined whether
ADAM10 also mediates the PKC-dependent CD44 ecto-
domain cleavage. Interestingly, depletion of ADAM10 had
very little effect on the TPA-induced production of CD44EXT
(Fig. 1 C, lane 3). In contrast, depletion of ADAM17 signifi-
cantly inhibited TPA-induced cleavage of CD44 (Fig. 1 C,
lane 4), which is related to the recent observation that phor-
bol ester PMA (phorbol 12-myristate 13-acetate) induces
ADAM17-dependent proteolysis of a neurotrophin receptor
TrkA (Diaz-Rodriguez et al., 2002) and TNF-
 
 
 
 processing
site peptide (Doedens et al., 2003). These results thus suggest
that the Ca
 
2
 
 
 
 influx-induced cleavage of the CD44 ecto-
domain is mediated by ADAM10, whereas that induced by
PKC activation is mediated by ADAM17.
 
Ca
 
2
 
 
 
 influx-induced CD44 ectodomain cleavage is 
inhibited in ADAM10-deficient mouse embryonic 
fibroblasts (MEFs)
 
To examine further the participation of ADAM10 in the
Ca
 
2
 
 
 
 influx-induced CD44 cleavage, we used ADAM10-
deficient (ADAM10
 
–/–
 
) MEFs (Fig. 2 A; Hartmann et al.,
2002). Immunoblot analysis showed that the amount of full
length CD44 was significantly reduced and CD44 EXT was
increased by extracellular Ca
 
2
 
 
 
 influx in wild-type MEFs
(Fig. 2 B, lane 3). However, CD44 EXT was hardly detected
in ADAM10
 
–/–
 
 MEFs by mechanical scraping (Fig. 2 B, lane
4). Because the expression levels of endogenous CD44 is
very low in MEFs, we confirmed the role of ADAM10
in the CD44 cleavage by transfecting the wild-type and
ADAM10
 
–/–
 
 MEFs with an expression vector encoding full-
length human CD44 (Fig. 2 C). The ectodomain cleavage
of the exogenous human CD44 was induced by mechanical
scraping in the wild-type and ADAM10
 
 
 
/–
 
 MEFs but not in
ADAM10
 
–/–
 
 MEFs. Moreover, we transfected the mouse
ADAM10 expression plasmid (unpublished data) back into
ADAM10
 
–/–
 
 MEFs and examine the CD44 cleavage. As
shown in Fig. 2 D, the expression of ADAM10 reconsti-
tuted the Ca
 
2
 
 
 
 influx-induced CD44 ectodomain cleavage
in ADAM10
 
–/–
 
 MEFs (Fig. 2 D). All these results indicate
that ADAM10 is the candidate sheddase for CD44 ecto-
domain cleavage in response to extracellular Ca
 
2
 
 
 
 influx.
 
Extracellular Ca
 
2
 
 
 
 influx and PKC activation differentially 
activate ADAM10 and ADAM17, respectively
 
We then examined the effect of Ca
 
2
 
 
 
 influx on the activation
of ADAM10 by immunoblot analysis with antibodies to this
protease. ADAM10 exists as an 
 
 
 
97-kD inactive, pro form
that is converted to the 68-kD active, mature form by cleav-
age at a consensus proprotein convertase cleavage motif
(Anders et al., 2001). Prodomain removal is thought to be a
prerequisite for ADAM10 activity. Calcium influx, triggered
by ionomycin, resulted in a marked increase in the amount of
Figure 2. Ca
2  influx-induced CD44 cleavage is inhibited in 
ADAM10 knockout MEFs (ADAM10
 /  MEFs). (A) Expression of 
pro form and mature (active) form of ADAM10 in wild-type (WT), 
ADAM10
 / , or ADAM10
 /  MEFs. Open arrowhead indicates a 
nonspecific band. (B) Wild-type (WT) or ADAM10
 /  MEFs were 
induced extracellular Ca
2  influx by mechanical scraping. After the 
scraping in the presence or absence of 10 mM EGTA, membrane 
fractions of these cells were collected and lysed with Laemmli 
sample buffer. The lysates were subjected to immunoblot analysis 
with anti-CD44cyto pAb. (C) Wild-type (WT), ADAM10
 / , or 
ADAM10
 /  MEFs were transiently transfected with either an 
expression plasmid for full-length human CD44 or the empty 
vector ( ). 2 d after transfection, the cells were subjected to 
mechanical scraping, incubated for 30 min, lysed, and immunoblotted 
with anti-CD44cyto pAb. Results are shown for two independent 
transfections of ADAM10
 /  MEFs. (D) ADAM10
–/– MEFs were 
cotransfected with an expression vector for full-length human CD44 
and an expression plasmid for mouse ADAM10. At 24 h after 
transfection, the cells were subjected to mechanical scraping, 
incubated for 30 min, lysed, and immunoblotted with anti-
CD44cyto pAb (top) or anti-ADAM10 (bottom). Open arrowhead 
indicates incompletely glycosylated CD44 protein. 
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the active form of ADAM10 in U251MG cells (Fig. 3 A; Fig.
1 B). Conversion of pro-ADAM10 to the active form in-
duced by ionomycin was inhibited in the presence of 10 mM
EGTA, indicating that extracellular Ca
 
2
 
 
 
 influx activates
ADAM10. Furthermore, in the course of this experiment, we
found that TPA treatment did not induce the conversion of
pro-ADAM10 to the active form (Fig. 3 B, top left; Fig. 1
C). These results suggest that ADAM10 is activated by extra-
cellular Ca
 
2
 
 
 
 influx but not by PKC activation.
Next, we examined the effect of TPA on ADAM17 activa-
tion in U251 MG cells. It has been reported recently that
PMA increases enzymatic activity of ADAM17 and subse-
quently active form of ADAM17 undergoes degradation
(Doedens et al., 2003). In fact, active form of ADAM17 is
degraded in time-dependent manner by TPA treatment in
the absence of BB94 (unpublished data). Therefore, to visu-
alize the active form of ADAM17, a metalloproteinase in-
hibitor needs to be present in the samples prepared for im-
munoblot analysis. In the presence of BB94, the active form
of ADAM17 could be detected by pAbs raised against cyto-
plasmic domain of ADAM17, and was accumulated in re-
sponse to TPA within 5–15 min, suggesting that TPA treat-
ment induced ADAM17 activation (Fig. 3 B, middle left).
However, accumulation of active ADAM17 was signifi-
cantly impaired in GF 109203X pretreated U251 MG cells
(Fig. 3 B, middle right). In addition, the active form of
ADAM17 was not increased but rather reduced in cells
treated with ionomycin (Fig. 3 A). Those data thus suggest
that Ca
 
2
 
 
 
 influx and PKC activation differentially activate
ADAM10 and ADAM17, respectively.
 
CaM inhibitor triggers ADAM10-mediated 
CD44 cleavage
 
To elucidate further the mechanism responsible for the Ca
 
2
 
 
 
influx-induced cleavage of CD44, we screened various cell-
permeable inhibitors of Ca
 
2
 
 
 
 signaling molecules for the
ability to affect this process. Neither 50 
 
 
 
M KN93, an in-
hibitor of Ca
 
2
 
 
 
- and CaM-dependent protein kinase II, nor
the calpain inhibitor Zlla1 (5–100 
 
 
 
M) affected CD44
ectodomain cleavage induced by mechanical scraping (un-
published data). In contrast, the CaM inhibitor trifluopera-
zine (TFP) markedly promoted both the conversion of the
pro form of ADAM10 to the active form as well as CD44
ectodomain cleavage in the absence of extracellular Ca
 
2
 
 
 
 in-
flux (Fig. 4 A). Moreover, the CD44 ectodomain cleavage
induced by TFP was inhibited by depletion of ADAM10,
but not by that of ADAM17, in U251MG cells. These find-
ings suggest that inhibition of CaM-mediated signals acti-
vates ADAM10 protease, leading to the ectodomain cleavage
of CD44. This hypothesis was also supported by the data
that TFP treatment induces CD44 cleavage in wild-type
MEFs but not in ADAM10-deficient MEFs (Fig. 4 B).
To further investigate the possibility of CaM-mediated in-
hibition of the CD44 ectodomain cleavage, we examined the
effect of CaM on the cell-free assay of CD44 cleavage, which
is mediated by ADAM10 activity as shown in Fig. S2 B. In-
cubation of membrane fractions of U251MG cells with puri-
fied CaM significantly impaired CD44 ectodomain cleavage
(Fig. 4 C, lanes 4 and 5). However, incubation of membrane
fractions with 100 
 
 
 
M TFP enhances CD44 ectodomain
cleavage (Fig. 4 C, lane 6) and further CaM-mediated inhibi-
tion of CD44 cleavage was significantly impaired in the pres-
ence of TFP (Fig. 4 C, lane 7) These observations thus
suggested a role for CaM in the regulation of ADAM10-
mediated cleavage of the ectodomain of CD44. In fact,
immunoblot analysis of CaM-bound proteins with anti-
ADAM10 revealed that pro form of ADAM10 specifically
associated with CaM in low Ca
 
2
 
 
 
 condition (concentration:
10
 
 
 
7
 
M; Fig. 4 D), whereas ADAM17 was not detected in the
CaM-binding fraction. These findings suggest that CaM in-
teracts with pro form of ADAM10 to inhibit the activation.
Furthermore, this in vitro interaction between ADAM10 and
CaM was impaired in the presence of 100 
 
 
 
M TFP (unpub-
lished data). On the basis of these observations, we propose
that activation of ADAM10 is regulated through a modifica-
tion of the CaM–ADAM10 association.
Figure 3. Activation of ADAM10 and ADAM17 are induced by 
Ca
2  influx and PKC activation, respectively. (A) U251MG cells 
were either left untreated or subjected to incubate with 5  M iono-
mycin for 15 or 30 min in the absence or presence of 10 mM EGTA. 
Cells were then lysed and subjected to immunoblot analysis with 
anti-ADAM10, anti-ADAM17, or  -tubulin. The intensities of the 
bands were measured with MacBAS2000 (Fuji Film), and the active 
form/total ADAM10 (or ADAM17) ratios were calculated. The numbers 
under each lane were expressed as a fold relative to control cells 
and were presented as mean values from three independent experi-
ments. Statistical differences were determined with t test; *, P   0.01. 
(B) U251MG cells were incubated with 10  M BB94 containing 
medium for indicated times in the absence or presence of 100 ng/ml 
TPA or 2.5  M GF109203X as indicated. Cell lysates were then 
subjected to immunoblot analysis with antibodies to ADAM10 (top) 
or ADAM17 (middle). The active form/total ADAM10 (or ADAM17) 
ratios were calculated as shown in A. The numbers under each lane 
were expressed as a fold relative to control cells and were presented 
as mean values from three independent experiments. Statistical dif-
ferences were determined with t test; *, P   0.01.Differential regulation of CD44 ectodomain cleavage | Nagano et al. 897
ADAM10 is responsible metalloproteinase for 
extracellular Ca
2  influx-induced cell detachment 
from HA matrix
Ca
2  influx induces the disassembly of cell–substratum ad-
hesions and is required for detachment of the rear cell mar-
gin in locomoting cells (Lee et al., 1999). Therefore, we ex-
amined whether the ADAM10 activation induced by Ca
2 
influx affects cell–substratum adhesion. Ionomycin induced
the rapid detachment of U251MG cells from an HA matrix
into culture medium and this effect was markedly inhibited
by the MMP inhibitor BB94 (Fig. 5, A and D). This effect
of ionomycin was observed in U251MG cells transfected
with control or ADAM17 siRNAs (Fig. 5, A, C, and D) but
not in ADAM10-depleted cells (Fig. 5, B and D). Further-
more, the ionomycin-induced cell detachment was inhibited
in ADAM10
 /  MEFs in comparison to wild-type and
ADAM10
 /  MEFs (Fig. S3, available at http://www.jcb.
org/cgi/content/full/jcb.200310024/DC1). These data indi-
cate that ADAM10-mediated cleavage of adhesion mole-
cules including CD44 is required for cells to detach from
matrix in response to extracellular Ca
2  influx.
Small GTPase Rac is involved in ADAM17-mediated 
CD44 ectodomain cleavage in response to 
TPA stimulation
TPA treatment induces the redistribution of CD44 to the
newly formed membrane ruffling areas, leading to the CD44
ectodomain cleavage in U251 MG cells (Okamoto et al.,
1999a). Thus, we investigated the subcellular localization of
ADAM17 after TPA treatment. As described previously
(Schlondorff and Blobel, 1999), ADAM17 was abundant in
the perinuclear region in U251MG cell without any treat-
ment. However, ADAM17 was redistributed to the ruffling
areas by TPA treatment and colocalized with CD44 within
10 min (Fig. 6 A).
As reported recently (Burridge and Wennerberg, 2004),
TPA treatment induced an increase in the GTP-bound Rac
within 5 min, whereas 5  M ionomycin treatment did not
(Fig. S4 A, available at http://www.jcb.org/cgi/content/full/
Figure 4. Interaction between CaM and ADAM10 regulates CD44 
ectodomain cleavage. (A) U251MG cells transfected with control, 
ADAM10, or ADAM17 siRNAs were incubated with 100  M TFP, 
a CaM inhibitor, for 30 min, after which cell lysates were prepared 
and subjected to immunoblot analysis with anti-CD44cyto pAb or 
with antibodies to ADAM10, ADAM17, or  -tubulin as indicated. 
(B) Wild-type (WT) or ADAM10
–/– MEFs were incubated with or 
without 100  M TFP for 30 min. After the incubation, membrane 
fractions of those cells were collected with hypotonic buffer 
containing 10  M BB94 and 10 mM EGTA. Collected membrane 
fractions were lysed with Laemmli sample buffer and subjected to 
immunoblot analysis with anti-CD44cyto pAb. (C) Membrane 
fractions isolated from U251MG cells were incubated for 2 h at 
37 C (lanes 2–8) in the presence of 10  M BB94 or indicated amounts 
of bovine brain CaM with or without 100  M TFP. All samples were 
then subjected to immunoblot analysis with anti-CD44cyto pAb 
(top) or anti-CaM antibody (bottom). The intensities of the CD44 
bands were measured with MacBAS2000, and the CD44EXT/total 
CD44 ratios were calculated. The bars under each lane were 
expressed as a fold relative to control cells. Note that the in vitro 
CD44 cleavage was inhibited by CaM in a dose-dependent manner 
(lanes 3–5) but that treatment with TFP significantly blocked the ef-
fect of CaM (lanes 6–8). (D) Agarose beads conjugated with either 
CaM or glutathione (GSH; negative control) were incubated with 
U251MG cell lysates in the presence of 0.1  M CaCl2. The input 
cell lysates and the beads-bound proteins were then subjected to 
immunoblot analysis with antibodies to ADAM10 (top), ADAM17 
(middle), or CaM (bottom).
Figure 5. Inhibition of Ca
2  influx-induced cell detachment from 
an HA matrix by depletion of ADAM10. (A–C) U251MG cells (2   
10
4) were seeded on HA-coated dishes and incubated for 24 h be-
fore transfection with (A) control, (B) ADAM10, or (C) ADAM17 si-
RNAs. 4 d after transfection, the cells were incubated in the presence 
of 5  M ionomycin for 30 min and examined by phase-contrast mi-
croscopy. (D) Cells transfected with control, ADAM10, or ADAM17 
siRNAs as in A–C were incubated with ionomycin for 30 or 60 min 
in the absence or presence of 10  M BB94, as indicated, after 
which floating cells were collected from the culture medium and at-
tached cells were harvested by exposure to trypsin. The numbers of 
both detached and attached cells were determined with a cell 
counter, and the number of detached cells was expressed as a per-
centage of the total cell number. Data are means   SEM of values 
from three to five independent experiments.898 The Journal of Cell Biology | Volume 165, Number 6, 2004
jcb.200310024/DC1). We also found previously that Rac is
involved in TPA-induced CD44 cleavage (Okamoto et al.,
1999a) and confirmed that expression of dominant negative
Rac inhibited the TPA-induced ruffling membrane forma-
tion and the CD44 relocalization (Fig. S4 B). These observa-
tions prompted us to test the hypothesis that Rac activation is
involved in the TPA/PKC-induced, ADAM17-mediated
CD44 cleavage. Immunoblot analysis revealed that ecto-
domain cleavage of CD44 in response to TPA is markedly
inhibited in U251MG cells transfected with Rac1N17, a
dominant negative form of Rac1 (RacDN; Fig. 6 B, lane 6)
but not in those transfected with Rac1V12, a dominant ac-
tive form of Rac1 (RacDA; lane 5). Furthermore, the conver-
sion of pro ADAM17 to active form after the TPA treatment
was significantly reduced in Rac1N17 transfected cells (Fig. 6
B, lane 6) although it was rather enhanced in Rac1V12 trans-
fected cells (lane 5). These results suggest that the activation
of Rac is required for TPA-induced ADAM17 activation.
Next, we analyzed the involvement of Rac activation in
ADAM17 localization. Expression of dominant active Rac
induced ADAM17 relocalization on the ruffling membrane
(Fig. 6 C, d–f), and TPA-induced membrane localization of
ADAM17 (Fig. 6 D) was clearly inhibited in cells expressing
dominant negative Rac (Fig. 6 D, a–c). These data indicate
that GTP bound form of Rac facilitates membrane localiza-
tion of ADAM17 and plays essential role in TPA-induced
CD44 cleavage.
ADAM10- and ADAM17-mediated CD44 ectodomain 
cleavages are both required for cancer cell migration 
on HA
Interaction of CD44 with HA is involved in response of
many cell types to inflammation, wound healing and cancer
cell migration (Oksala et al., 1995; Okamoto et al., 1999b;
Bourguignon et al., 2000; Tammi et al., 2001). We investi-
gated the role of ADAM10 or ADAM17 in CD44-depen-
Figure 6. Small GTPase Rac is involved in TPA-induced ADAM17 activation and CD44 cleavage. (A) U251 MG cells were incubated with 
or without 100 ng/ml of TPA for 5 min and cells were double stained with anti-HA or ADAM17 antibody. Bar, 20  m. Arrowheads indicate 
redistribution of CD44 and ADAM17 at the TPA-induced ruffling membrane areas. (B) U251 MG cells were transfected with mock vector, 
HA-Rac1V12 (a dominant active form of Rac1 indicated as RacDA), or HA-Rac1N17 (a dominant negative form of Rac1 indicated as RacDN). 
At 24 h after transfection, cells were incubated with 100 ng/ml of TPA for 20 min and subjected to immunoblot analysis with anti-CD44cyto, 
ADAM17, HA (12CA5), and  -tubulin. Note that TPA-induced CD44 cleavage and ADAM17 activation were significantly inhibited by 
expression of RacN17 (DN) (lane 6). The intensities of the bands were measured with MacBAS2000, and the active form/total ADAM17 ratios 
were calculated. The numbers under each lane were expressed as a fold relative to control cells and were presented as mean values from 
three independent experiments. Statistical differences were determined with t test; *, P   0.01. (C) The cells transfected with Rac N17 (DN) 
(a–c) or RacV12 (DA) (d–f) were fixed at 24 h after the transfection, and double stained with anti-HA and anti-ADAM17. Note that expression of 
RacV12 (DA) induced ADAM17 relocalization on the ruffling membrane (d–f, arrowheads). (D) The cells transfected with Rac N17 (DN) (a–c) or 
RacV12 (DA) (d–f) were incubated with TPA for 5 min and double stained with anti-HA and anti-ADAM17. Note that TPA-induced membrane 
localization of ADAM17 was inhibited by expression of Rac N17 (DN) (a–c). Arrows indicate RacV12 (DA) or Rac N17 (DN) expressed cells.Differential regulation of CD44 ectodomain cleavage | Nagano et al. 899
dent cell migration on HA with an in vitro transwell mi-
gration assay in cultures of RERF-LC-OK human lung
adenocarcinoma cells. In these cells, CD44 cleavage was pre-
viously shown to play a critical role in migration on HA
(Okamoto et al., 1999a). Treatment with a metalloprotease
inhibitor significantly reduced RERF-LC-OK cell migration
through HA-coated membrane, demonstrating a require-
ment for MMP activity in migration on HA. As shown in
Fig. 7, depletion of ADAM10 or ADAM17 markedly re-
duced cell migration through HA-coated membrane al-
though cell migration was not inhibited when fibronectin-
coated membrane was used. These results thus suggest that
the CD44 ectodomain cleavages mediated by ADAM10 and
ADAM17 contribute to cancer cell motility on HA matrix.
Discussion
ADAM10 and ADAM17 are responsible for 
CD44 cleavage
A large variety of membrane proteins, including collagen
XVII (Franzke et al., 2002),  -amyloid precursor protein
(Buxbaum et al., 1998), cellular prion protein (Vincent et
al., 2001), CX3CL1 (Hundhausen et al., 2003), and HB-
EGF (Yan et al., 2002) have been determined to be sub-
strates for ADAM family proteases. However, the relations
between the nature of the stimulus and the specific ADAM
proteases responsible for the cleavage of these proteins are
largely unknown.
It has been reported that ADAM10 and ADAM17 have
sequence similarity and share several substrates (Rosendahl
et al., 1997; Vincent et al., 2001; Hundhausen et al., 2003).
Moreover, ADAM10 and ADAM17 have been reported re-
cently to have critical role in shedding of six different EGFR
ligands (TGF- , amphiregulin, epiregulin, HB-EGF, beta-
cellulin, and EGF) in MEFs (Sahin et al., 2004). Here, we
have shown that cleavage of the ectodomain of CD44 is me-
diated by ADAM10 and ADAM17, and that the activation
of these proteases is triggered by distinct stimuli and signal-
ing pathways (Fig. S5, available at http://www.jcb.org/cgi/
content/full/jcb.200310024/DC1).
CaM regulates ADAM10-mediated CD44 proteolysis
We have shown that extracellular Ca
2  influx induces
ADAM10-mediated CD44 cleavage and that CaM inhibitor
TFP, which have high affinity to Ca
2 /CaM, activates the
ADAM10-mediated CD44 cleavage without Ca
2  influx.
Because we found that pro-ADAM10 interacts with CaM
and that the interaction is disrupted by TFP, we hypothesize
that Ca
2  influx triggers the dissociation of CaM from pro-
ADAM10, resulting in the activation of ADAM10. Re-
cently, it was reported that the association between CaM
and its binding proteins is defined by the affinities, Ca
2 
sensitivities and concentrations of all CaM-binding protein
in the cell (Tran et al., 2003). Furthermore, it was shown
that increasing intracellular Ca
2  concentration decreased
the amounts of membrane bound CaM in neuroblastoma
cells (McGinnis et al., 1998). These observations suggest
that CaM may change their localization and substrates by al-
teration of cytosolic Ca
2  concentration. In fact, studies us-
ing confocal imaging of CaM labeled with a fluorescent
probe showed that the influx of extracellular Ca
2  induces
redistribution of CaM within the cell (Liao et al., 1999) and
that spikes of increasing Ca
2  concentration trigger spikes of
decreasing cytosolic CaM concentration by translocation of
CaM to the secretory granule region or nucleoplasm (Craske
et al., 1999; Ashby and Tepikin, 2002). Therefore, the sim-
plest model would be that CaM constitutively associates
with pro-ADAM10 in resting cells at low affinity (intracellu-
lar Ca
2  concentration: 10
 7–10
 6 M) and a rapid decrease
in the local cytosolic concentration of CaM by altering their
substrates and localization after Ca
2  influx (extracellular
Ca
2  concentration:  10
 3 M) may promote dissociation of
CaM from ADAM10, resulting in activation of ADAM10
and the consequent proteolysis of CD44. The CaM inhibi-
tor TFP has been reported to induce the ectodomain cleav-
age of several other membrane proteins, such as L-selectin
(Kahn et al., 1998), TrkA and proTGF  (Diaz-Rodriguez et
al., 2000), raising the possibility that these TFP-sensitive
membrane proteins are also cleaved by activated ADAM10.
ADAM10 plays a critical role in Ca
2  influx-induced 
cell detachment from matrix
Ca
2  regulates many processes that are required for cell
movement, including production of actomyocin-based con-
tractile forces, regulation of the actin cytoskeleton, forma-
tion, and disassembly of cell substratum interaction (Stroh-
meier and Bereiter-Hahn, 1984; Lee et al., 1999). Thus,
extracellular Ca
2  influx is considered to contribute high cell
motility through impairing cell–matrix adhesion. However
little is known about the roles of extracellular proteolysis of
adhesion molecules triggered by extracellular Ca
2  influx in
the release of cell–matrix interaction. We have now demon-
Figure 7. Effects of ADAM depletion on RERF-LC-OK 
cells migration on HA. (A) The effects of ADAM10- or 
ADAM17-depletion on migration of RERF-LC-OK cells on 
HA were assessed by modified Boyden chamber-type 
migration assays. RERF-LC-OK cells were transfected with 
control, ADAM10, or ADAM17 siRNAs and cultured for 
4 d before cells were subjected to migration assays. 
Columns and error bars represent the mean and SD 
obtained from three independent experiments. Statistical 
differences were determined with t test; *, P   0.01. 
(B) Migration of RERF-LC-OK cells on fibronectin was 
assessed by the migration assays as in A. (C) Inhibition of 
ADAM10 or ADAM17 expression in RERF-LC-OK cells by RNA interference. Cells were transfected with control, ADAM10, or ADAM17 siRNAs 
and cultured for 4 d. Equal amounts of cell lysates were then subjected to immunoblot analysis with antibodies to ADAM10 or to ADAM17.900 The Journal of Cell Biology | Volume 165, Number 6, 2004
strated that extracellular Ca
2  influx induces detachment of
U251MG cells from HA matrix through ADAM10-depen-
dent proteolysis (Fig. 5). This result suggests that ADAM10
is the responsible enzyme for the termination of links be-
tween adhesion molecules and matrix in response to extra-
cellular Ca
2  influx.
Small GTPase Rac regulates subcellular localization 
and activity of ADAM17
We previously showed that the Rho family of small G pro-
teins including Rho and Rac are involved in TPA/PKC-
induced redistribution and cleavage of CD44 (Okamoto et
al., 1999a). Here, we have shown that Rac activation triggered
by TPA treatment induces redistribution of ADAM17 to
ruffling areas and that the expression of dominant negative
Rac inhibits the TPA-induced ADAM17 redistribution and
activation. It was reported that pro-ADAM17 is processed
and converted to the active form in the secretory pathway
and, thereby, the active form of ADAM17 is detected on the
plasma membrane whereas the majority of pro-ADAM17
localizes to a perinuclear compartment (Schlondorff and
Blobel, 1999). This observation together with our findings
suggests that TPA-mediated Rac activation promotes the re-
distribution of both pro form of ADAM17 and CD44 to the
plasma membrane, leading to ADAM17 activation and clus-
tering of the activated protease and substrate, which might
be required for triggering the proteolytic processing.
It should be noted that the expression of a dominant ac-
tive form of Rac1 (Rac1V12) did not induced CD44 cleav-
age in the absence of TPA stimulation (Fig. 6 B, lane
2). This result suggests that activation of Rac is required
for ADAM17-mediated CD44 cleavage, but Rac activation
alone is not sufficient for the induction of cleavage without
PKC activation. We speculate that both Rac and PKC acti-
vation, which are induced by TPA treatment, are necessary
for the activation of ADAM17 to cleave CD44.
Biological significance of CD44 ectodomain cleavage 
differentially regulated by ADAM10 and ADAM17 in 
cancer cell migration on HA
HA contributes to cell migration as a structural component
of the extracellular space, creating a highly hydrated, elastic
matrix that may help cell movement by facilitating detach-
ment and providing space for migration (Tammi et al.,
2001). CD44 ectodomain cleavage has shown to require for
efficient cancer cell migration on HA matrix (Okamoto et
al., 1999b). Our present observation suggests that CD44
ectodomain cleavages mediated by ADAM10 and ADAM17
are equally required for efficient migration of cancer cells on
HA (Fig. 7). Although the precise mechanisms by which
ADAM10 and ADAM17 are activated to regulate the cell
migration on HA matrix remain to be elucidated, we specu-
late that this process is achieved by two sequential steps: (1)
activation of Rac at leading edge of cells induces redistribu-
tion and activation of ADAM17, leading to efficient cell
crawling on HA through CD44 ectodomain cleavage; and
(2) this mechanical stretching of cell is known to induce ex-
tracellular Ca
2  influx through the stretch activated Ca
2 
channel (Lee et al., 1999), resulting in rapid activation of
ADAM10 followed by CD44 cleavage, facilitating cell de-
tachment from HA at rear end of the migrating cell.
CD44 ectodomain cleavage plays critical roles in not only
cancer invasion and metastasis but also various physiological
events, such as wound healing, lymphocyte homing, cell mi-
gration, and cell proliferation. Therefore, the simple ap-
proaches to reduce the cleavage by metalloproteinase inhibi-
tion may not be applied to the therapy because diverse
physiological processes are potentially impaired. The exist-
ence of independent–differential pathways for CD44 cleav-
age may permit us to develop selective therapeutical ap-
proaches to suppress cancer invasion and metastasis.
Materials and methods
Cell culture and reagents
U251MG and RERF-LC-OK cells were grown in DME F12 supplemented
with 10% FCS. MEF cell lines from ADAM10
 /  mice and respective
wild-type mice were generated and characterized as described previ-
ously (Hartmann et al., 2002). MEFs were cultured in DME containing
10% FCS. pAb against the cytoplasmic domain of CD44, anti-CD44cyto
pAb was generated as described previously (Okamoto et al., 1999a). The
mAb directed against the ectodomain epitope of CD44 (BU52) was ob-
tained from Ancell. Anti-ADAM10 antibody directed against cytoplasmic
domain was purchased from Calbiochem. Anti-ADAM17 antibody di-
rected against cytoplasmic domain was purchased from CHEMICON In-
ternational, Inc. and Calbiochem. Anti-ADAM17 (H-300) was obtained
from Santa Cruz Biotechnology. Anti-CaM and anti-Rac were purchased
from Upstate Biotechnology. The anti-HA mAb was prepared from
12CA5 cells. Materials were obtained as follows: recombinant hTIMP-1,
-2, and -3 were provided by K. Iwata (Daiichi Fine Chemical Industries
Ltd., Takaoka, Japan). Purified bovine brain CaM were obtained from
Sigma-Aldrich; PAK-1 PBD agarose was purchased from Upstate Bio-
technology; GF109203X, ionomycin, and TFP were purchased from Cal-
biochem; and BB94 (batimastat) was provided by W.G. Stetler-Stevenson
(National Institutes of Health, Bethesda, MD).
Cell-free assay of CD44 cleavage
Membrane fractions of U251MG cells were obtained as described pre-
viously (Okamoto et al., 1999a) with slight modifications. Cultured
U251MG cells were incubated for 15 min on ice with hypotonic buffer (20
mM Hepes-KOH, pH 7.5, 10 mM potassium acetate, 1.5 mM magnesium
acetate) supplemented with 10 mM EGTA and a protease inhibitor cocktail
(Sigma-Aldrich). They were then disrupted by 30 strokes with a Dounce
homogenizer. Nuclei were removed from the homogenate by centrifuga-
tion at 2,000 g for 5 min at 4 C, and the resulting supernatant was then
centrifuged at 10,000 g for 1 h at 4 C. The new membrane pellet was sus-
pended in an ice-cold solution of 30 mM tris-HCl, pH 7.2, containing 1
mM CaCl2 or 10 mM EGTA, and various test agents and incubated for 2 h
at 37 C. The reaction was stopped by the addition of an equal volume of
Laemmli sample buffer and heating at 95 C for 5 min.
Immunoblot analysis
Cells were directly lysed in 2  Laemmli buffer or cell lysis buffer contain-
ing 0.1 M DTT. For immunoblot analysis of active form of ADAM10 and
ADAM17, 10  M BB94 were added to the culture medium to block degra-
dation. Equal amounts of protein were separated by SDS-PAGE, transferred
onto nitrocellulose membrane, and incubated with antibodies. All immu-
noblots were visualized by Chemiluminescence Reagent Plus (Perkin-
Elmer).
Plasmids and siRNA transfection
A cDNA encoding full-length CD44 was constructed as described previ-
ously (Okamoto et al., 2001). pEF-BOS-HA- Rac1WT (wild-type Rac1),
Rac1V12 (a constitutive active form of Rac1), and Rac1N17 (a dominant
negative form of Rac1) plasmids were provided by K. Kaibuchi (Nagoya
University, Nagoya, Japan; Kuroda et al., 1996). These expression plas-
mids were transfected into cells using LipofectAMINE and PLUS Reagent
(Life Technologies, Inc.) according to the manufacturer’s instruction. The
sequences of the siRNAs were as follows: human ADAM10, 5 -GACAU-
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3 ; human ADAM17, 5 -CACAUGUAGAAACACUACUTT-3  and 5 -
AGUAGUGUUUCUACAUGUGTT-3 . A double-stranded RNA targeting
luciferase (GL-2) was used as a control: 5 -CGUACGCGGAAUACUUC-
GATT-3  and 5 -UCGAAGUAUUCCGCGUACGTT-3 . The 21-nt chimeric
RNA-DNA duplexes were obtained from Japan Bioservice. Cells were
transfected with annealed siRNAs with the use of Oligofectamine (Life
Technologies).
In vitro binding assay
U251MG cells (5   10
6) were washed with ice-cold PBS and incubated for
15 min on ice in 1 ml of a lysis buffer (50 mM tris-HCl, pH 7.4, 50 mM
NaCl, 3 mM MgCl2, 0.5% NP-40, 10 mM DTT) supplemented with 10 mM
NaF, 10  M BB94, and a protease inhibitor cocktail (Sigma-Aldrich). They
were then homogenized by passage through a 25-gauge needle, and the
homogenate was centrifuged at 14,000 g for 15 min at 4 C. The resulting
supernatant (500  l) was mixed with 20  l of agarose beads conjugated
with either glutathione or CaM (Sigma-Aldrich) and was then rotated for
2 h at 4 C, after which the beads were washed three times with lysis buffer
containing 0.1  M CaCl2 and subjected to immunoblot analysis. For GTP-
Rac pull-down assay, control, 100 ng/ml TPA, or 5  M ionomycin stimu-
lated U251MG cells were lysed with magnesium-containing buffer (25
mM Hepes, pH 7.5, 150 mM NaCl, 1.0% NP-40, 10% glycerol, 10 mM
MgCl2, 1 mM EDTA) supplemented with 25 mM NaF, 1 mM sodium ortho-
vanadate, 10  M BB94, and a protease inhibitor cocktail (Sigma-Aldrich).
They were then homogenized by passage through a 25-gauge needle, and
the homogenate was centrifuged at 14,000 g for 5 min at 4 C. The result-
ing supernatant was mixed with 5  g of PAK1 PBD agarose (Upstate Bio-
technology) and was then rotated for 1 h at 4 C, after which the beads
were washed four times with lysis buffer and subjected to immunoblot
analysis with anti-Rac antibody.
HA coating and cell detachment assay
HA coated culture dish was prepared as described previously (Peck and
Isacke, 1996). For coating with HA, 35-mm Petri dishes were incubated for
32 h at 4 C with 500  l of streptococcal hyaluronan (5 mg/ml; Sigma-
Aldrich). An equal volume of 2% BSA was added and the plates were incu-
bated for an additional 16 h. They were then washed three times with DME
F12 and used immediately. U251MG cells were seeded on the HA-coated
dishes 1 d before siRNA transfection and were cultured in DME F12 supple-
mented with 10% FBS. 4 d after transfection, the cells were incubated with
5  M ionomycin in serum-free medium for the indicated times.
Immunofluorescence microscopic analysis
U251 cells grown on 35-mm culture dishes were fixed with 4% PFA for 15
min followed by 0.2% Triton X-100 in PBS for 5 min. After being washed
with PBS, the cells were incubated in primary antibodies diluted in PBS
containing 0.2% BSA for 60 min at RT, washed three times in PBS, and in-
cubated for 60 min at RT with appropriate secondary antibodies linked to
fluorescein isothiocyanate and Cy 5 diluted in PBS containing 0.2% BSA.
After being washed with PBS, samples were mounted in 80% glycerol and
visualized with a confocal microscope (model Fluoview; Olympus).
Migration assay
Migration assay using RERF-LC-OK cells were performed as described pre-
viously (Okamoto et al., 1999b). Cell migration was performed using 48-
well modified Boyden chambers (Neuro Probe Inc.) with polycarbonate fil-
ters of 8- m pore size (Nucleopore Corp.). The undersides of filters were
precoated with 1 mg/ml HA (Sigma-Aldrich).
Online supplemental material
Fig. S1 shows that CD44 cleavage is regulated by different signals. Fig.
S2 demonstrates characterization of metalloproteinases responsible for
ectodomain cleavage of CD44. Fig. S3 shows that Ca
2  influx-induced cell
detachment from an HA matrix is suppressed in ADAM10
 /  MEFs. Fig. S4
shows that Rac activation is induced by TPA treatment and regulates mem-
brane ruffling in U251MG cells. Fig. S5 illustrates the proposed model for
regulation of ADAM10- and ADAM17-mediated CD44 ectodomain cleav-
ages triggered by the distinct signaling pathways. Online supplemental is
available at http://www.jcb.org/cgi/content/full/jcb.200310024/DC1.
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